FDA approves Hibsago (bepirovirsen), a first-in-class treatment that may let some hepatitis B patients stop therapy
On 20 October 2026 the FDA approved GSK's Hibsago (bepirovirsen) injection for chronic hepatitis B.
On 20 October 2026 the FDA approved GSK's Hibsago (bepirovirsen) injection for chronic hepatitis B.
Confirmed Ebola cases in the Democratic Republic of the Congo reached 9,704 by 20 October 2026, including 4,687 deaths.
On 18 November 2026 the FDA approved Sanofi's Infilbray (venglustat).
An IAEA-coordinated research project involving 27 countries studied how biological markers can measure patients' exposure to ionising radiation.
An international study coordinated by the IAEA and Columbia University analysed radiation doses in more than 19,000 patients in 101 countries.
On 26 April 1986 an explosion and fires at the Chernobyl plant caused the largest uncontrolled radioactive release in the history of civil nuclear power.
On 2 October 2026 the FDA approved Jaypirca (pirtobrutinib) for adults with previously untreated chronic lymphocytic leukemia.
An Aesthetic Surgery Journal article examines the ethics of surgeons analysing celebrities' looks on social media.
On 9 October 2026 the FDA approved Hovilpri (pritelivir) tablets for herpes simplex lesions in immunocompromised adults.
On 8 October 2026 The Lancet published a Google and Beth Israel Deaconess Medical Center study of the AMIE diagnostic AI.
Nothing more to show